AAAAAA

   
Results: 1-8 |
Results: 8
Hypertension in the Very Elderly Trial (HYVET) - Protocol for the Main Trial
Authors: Bulpitt, C Fletcher, A Beckett, N Coope, J Gil-Extremera, B Forette, F Nachev, C Potter, J Sever, P Staessen, J Swift, C Tuomilehto, J
Citation: C. Bulpitt et al., Hypertension in the Very Elderly Trial (HYVET) - Protocol for the Main Trial, DRUG AGING, 18(3), 2001, pp. 151-164
Interaction between nonsteroidal anti-inflammatory drug intake and calcium-channel blocker-based antihypertensive treatment in the Syst-Eur trial
Authors: Celis, H Thijs, L Staessen, JA Birkenhager, WH Bulpitt, CJ de Leeuw, PW Leonetti, G Nachev, C Tuomilehto, J Fagard, RH
Citation: H. Celis et al., Interaction between nonsteroidal anti-inflammatory drug intake and calcium-channel blocker-based antihypertensive treatment in the Syst-Eur trial, J HUM HYPER, 15(9), 2001, pp. 613-618
Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension
Authors: Voyaki, SM Staessen, JA Thijs, L Wang, JG Efstratopoulos, AD Birkenhager, WH de Leeuw, PW Leonetti, G Nachev, C Rodicio, JL Tuomilehto, J Fagard, R
Citation: Sm. Voyaki et al., Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension, J HYPERTENS, 19(3), 2001, pp. 511-519
Reduced concentrations of soluble adhesion molecules after antioxidant supplementation in postmenopausal women with high cardiovascular risk profiles- A randomized double-blind study
Authors: Goudev, A Kyurkchiev, S Gergova, V Karshelova, E Georgiev, D Atar, D Kehayov, I Nachev, C
Citation: A. Goudev et al., Reduced concentrations of soluble adhesion molecules after antioxidant supplementation in postmenopausal women with high cardiovascular risk profiles- A randomized double-blind study, CARDIOLOGY, 94(4), 2000, pp. 227-232
Systolic Hypertension in Europe (Syst-Eur) Trial Phase 2: objectives, protocol, and initial progress
Authors: Gasowski, J Staessen, JA Celis, H Fagard, RH Thijs, L Birkenhager, WH Bulpitt, CJ Fletcher, AE Arabidze, GG de Leeuw, P Dollery, CT Duggan, J Kawecka-Jaszcz, K Leonetti, G Nachev, C Safar, M Rodico, JL Rosenfeld, J Seux, ML Tuomilehto, J Webster, J Yodfat, Y
Citation: J. Gasowski et al., Systolic Hypertension in Europe (Syst-Eur) Trial Phase 2: objectives, protocol, and initial progress, J HUM HYPER, 13(2), 1999, pp. 135-145
Serum level of IgG autoantibodies against oxidized low density lipoproteins and lag-phase of serum oxidation in coronary heart disease - Inverse correlation
Authors: Bakalova, R Zhelev, Z Goudev, A Ribarov, S Nachev, C
Citation: R. Bakalova et al., Serum level of IgG autoantibodies against oxidized low density lipoproteins and lag-phase of serum oxidation in coronary heart disease - Inverse correlation, GEN PHYSL B, 18(1), 1999, pp. 87-97
Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension
Authors: Staessen, JA Thijs, L Fagard, R O'Brien, ET Clement, D de Leeuw, PW Mancia, G Nachev, C Palatini, P Parati, G Tuomilehto, J Webster, J
Citation: Ja. Staessen et al., Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension, J AM MED A, 282(6), 1999, pp. 539-546
Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension
Authors: Tuomilehto, J Rastenyte, D Birkenhager, WH Thijs, L Antikainen, R Bulpitt, CJ Fletcher, AE Forette, F Goldhaber, A Palatini, P Sarti, C Fagard, R Staessen, JA Arabidze, GG Carrageta, M Celis, H Kocemba, J Leonetti, G Nachev, C O'Brien, ET Ritz, E Rodicio, JL Rosenfeld, J Heyrman, J Stibbe, G Van den Haute, H Yodfat, Y De Cort, P Hubner, GE
Citation: J. Tuomilehto et al., Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension, N ENG J MED, 340(9), 1999, pp. 677-684
Risultati: 1-8 |